CD33 competitive inhibitor peptide IMAD‐001 modulates innate immunity in Alzheimer’s disease

Green, J. L., Dressman, D., Rashid, M., Hobson, R., Elyaman, W., & Bradshaw, E. M. (2024). CD33 competitive inhibitor peptide IMAD‐001 modulates innate immunity in Alzheimer’s disease. Alzheimer’s & Dementia, 20(S6). Portico. https://doi.org/10.1002/alz.089331
Authors:
Jennifer L. Green
Dallin Dressman
Mamun Rashid
Ryan Hobson
Wassim Elyaman
Elizabeth M. Bradshaw
Affiliated Authors:
Jennifer L. Green
Dallin Dressman
Mamun Rashid
Ryan Hobson
Wassim Elyaman
Elizabeth M. Bradshaw
Columbia Affiliation:
Subjects:
Neuroimmune Interaction in Psychiatric Disorders (OpenAlex Topic)
Trained Immunity in Health and Disease (OpenAlex Topic)
Macrophage Activation and Polarization (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1002/alz.089331
DOI:
10.1002/alz.089331
Journal:
Alzheimer's and Dementia
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: